What regulatory guidelines apply to (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4)?
The compound (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). It is also covered by REACH regulations in the European Union, and may require registration with the U.S. EPA under TSCA. Specific safety data sheets (SDS) should be consulted for detailed information on handling and storage conditions.
Are there alternatives to (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one in synthesis?
In the synthesis of (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4), chemists may consider using analogous compounds like (3S,7S)-7,14-dihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one, or substituting with other isomers or reagents that offer similar functional groups. These alternatives can provide a pathway for more efficient or safer synthesis.
What is the market or research trend for (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4)?
The market for (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4) is expected to grow due to its potential applications in medicinal chemistry and pharmaceuticals. Research trends indicate an increasing focus on its use as a bioactive molecule, particularly in drug discovery and development. Additionally, the compound's use in natural product synthesis and as a precursor in organic synthesis is also gaining attention.
How should waste containing (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4) be handled?
Waste containing (3S,7S)-7,14,16-Trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one (CAS: 42422-68-4) should be collected in appropriate containers and stored safely to prevent environmental contamination. Disposal should follow local regulations, and professional waste disposal services may be necessary. Incineration can be a suitable method for disposal, provided it is conducted in an environmentally controlled incinerator. Additionally, proper labeling and documentation of waste are essential to ensure compliance with regulatory requirements.